AVROBIO Inc
NASDAQ: avro
$1.40
USD
-$0.05
-3.45%
Prev Close
$1.45
Today's Open
$1.46
Volume
267.36K
Market Cap
61.11M
Day Range
52W Range
Overview
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts.
Read moreCurrent Price
15 min delay
Catalysts
There are currently no catalysts for AVRO. If there's something you'd like to see, feel free to reach out to us on discord.
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)
Insufficient Data
Ratios
Valuation Ratios
EPS (TTM)
-2.862
P/E Ratio
0
Price to Sales
0
Price to Book
0.343
Profit Ratios
Profit Margin
0.00%
EBITDA Margin
-Infinity%
Net Profit Margin
-
ROA
-33.10%
Total Revenue
$0.00
Net Profit
$0.00
EV to EBITDA
1.147
EV to Revenue
0